ive birth rate after metformin and clomiphene vs clomiphene alone in polycystic ovary syndrome (PCOS): a randomized, double-blind, placebo-controlled trial.
Phase 4
Completed
- Conditions
- polycystic ovary syndromesubfertilityReproductive Health and Childbirth - Fertility including in vitro fertilisation
- Registration Number
- ACTRN12613000027718
- Lead Sponsor
- Dr Clare Boothroyd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Female
- Target Recruitment
- 80
Inclusion Criteria
women with polycystic ovary syndrome, desiring pregnancy, with subfertility
Exclusion Criteria
Women were excluded from the study if they had other causes of anovulation (specifically hyperprolactinaemia, hypothyroidism and congenital adrenal hyperplasia), diabetes mellitus or if the semen analysis of their partner indicated male factor subfertility
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method